• Aucun résultat trouvé

<< Back to Publications >> Go to Table of Contents

N/A
N/A
Protected

Academic year: 2022

Partager "<< Back to Publications >> Go to Table of Contents"

Copied!
89
0
0

Texte intégral

(1)
(2)
(3)

<< Back to Publications >> Go to Table of Contents

(4)

CONTENTS

Foreword vii

1. Introduction 1

1.1 The role of herbal medicines 1 1.2 WHO's policy on herbal medicines 1 1.3 The need for the guidelines on the appropriate 3 use of herbal medicines 2. Goals and objectives of the guidelines 5 2.1 Goals 5 2.2 Objectives 5

3. Definitions 6

4. National policy development 9 4.1 Process for the development of a policy 9 for herbal medicine 4.2 Issues to be included in the policy 10

5. Development of a national programme 14

on herbal medicines 5.1 National management body for the herbal 14

medicine programme 5.2 Use of herbal medicines in health care 15

5.3 Research on herbal medicines 16

5.4 Preparation of information on medicinal plants 16

5.5 Conservation of medicinal plants 17

(5)

5.6 Training and education 18 5.7 Collection and exchange of information 18

on herbal medicines

6. Regulation of practitioners 19

6.1 Options 19

6.2 Examination 19

7. Regulation on the manufacture and distribution 21 of medicinal herbal products

7.1 General considerations 21

7.2 Good manufacturing practices (GMP) 22

7.3 Training of regulatory staff 22

7.4 WHO certification scheme on the quality 23 of pharmaceutical products moving

in international commerce

8. Regulation of herbal medicines 24

8.1 General considerations 24

8.2 Requirements for raw plant materials 27 8.3 Requirements for processed plant materials 28 8.4 Requirements for medicinal herbal products 29

8.5 Label requirements 32

8.6 Responsible government agency for regulation 33 8.7 Promotion and advertisement of herbal 34

medicines

8.8 Monitoring of adverse reactions to herbal 34 medicines

9. Use of the guidelines 35

(6)

Annexes 36

1 Report of the meeting of the working group 36 on herbal medicines

2 List of temporary advisers, consultants 62 observers and secretariat

3 Agenda 69

4 Opening Speech of Dr S.T Han 71

WHO Regional Director of the Western Pacific Region working Group on Herbal Medicines, 8 December 1997

Manila, Philippines

5 Closing Remarks of Dr S.T. Han, 74

WHO Regional Director of the Western Pacific Region Working Group on Herbal Medicines, 12 December 1997,

Manila, Philippines

References 76

<< Back to Publications << Back to Main Page

(7)
(8)

<< Back to Table of Contents

(9)
(10)
(11)
(12)

<< Back to Table of Contents

(13)

<< Back to Table of Contents

(14)
(15)
(16)

<< Back to Table of Contents

(17)
(18)
(19)
(20)
(21)

<< Back to Table of Contents

(22)
(23)
(24)
(25)
(26)

<< Back to Table of Contents

(27)
(28)

<< Back to Table of Contents

(29)
(30)
(31)

<< Back to Table of Contents

(32)
(33)
(34)
(35)
(36)
(37)
(38)
(39)
(40)
(41)
(42)

<< Back to Table of Contents

(43)

<< Back to Table of Contents

(44)
(45)
(46)
(47)
(48)
(49)
(50)
(51)
(52)
(53)
(54)
(55)
(56)
(57)
(58)
(59)
(60)
(61)
(62)
(63)
(64)
(65)
(66)
(67)
(68)
(69)

<< Back to Table of Contents

(70)
(71)
(72)
(73)
(74)
(75)
(76)

<< Back to Table of Contents

(77)
(78)

<< Back to Table of Contents

(79)

<< Back to Table of Contents

(80)
(81)
(82)

<< Back to Table of Contents

(83)
(84)

<< Back to Table of Contents

(85)

<< Back to Table of Contents

(86)
(87)
(88)
(89)

Références

Documents relatifs

Annex 4 List of members, observers and secretariat of the working group on Clinical Research Methodology for Acupuncture, Aomori, Japan,. 1-4 June 1994

Currently, the WHO Eastern Mediterranean, South-East Asia and Western Pacific Regions are working on adapting the WHO Nutrient Profile Model to the Region that

Five cities in the Western Pacific Region (Changwon, the Republic of Korea; Marikina, the Philippines; Nagoya, Japan; Phnom Penh, Cambodia; and Seoul, the Republic of Korea)

Regulatory strengthening for medicines and the health workforce is a priority for countries in the Western Pacific Region, and convergence and cooperation offer an opportunity to

The Western Pacific Region entered the second decade of the 21st century with continued regional progress towards achieving immunization goals, including strengthening immunization

On behalf of Dr Shigeru Omi, WHO Regional Director for the Western Pacific, I would like to thank the Ministry of Health in Cook Islands for hosting the Second Meeting of the

The Regional Committee, having reviewed and noted the report Operationalizing the Programme Budget 2020–2021 in the Western Pacific Region, expresses its

The Western Pacific Regional Action Agenda on Regulatory Strengthening, Convergence and Cooperation for Medicines and the Health Workforce guides Member States in